The board of directors at ImmunoMet Therapeutics has a history of experience in the pharmaceutical industry and in education. Members have served as interim Chief Scientific Officer at APIE Therapeutics and as a member of the Chimeron SAB at Chimeron Bio. Additionally, they have acted as CSO at Complexa Inc. and President at POC Pharma Consulting, LLC. All members of the board have a pharmacology background from UMDNJ-Rutgers.
View all